This is why Mounjaro is covered by most insurance companies while Zepbound is not
Key Market Projections: 2024: Analysts project Zepbound sales to be in the range of $2 billion to $3 billion for the full year, reflecting its initial launch and increasing uptake [1]
, and his dedicated team are here to guide you through every step of your journey
This makes them incredibly appealing for individuals who may already have their diet locked in, but still face metabolic resistance or stubborn pockets of tissue
Stable Blood Sugar Levels: By enhancing insulin sensitivity and promoting more effective blood sugar regulation, these medications benefit those who may struggle with prediabetes or insulin resistance
Moreover, unlike GLP-1 drugs that sometimes cause muscle loss, particularly concerning for elderly users, SANA specifically burns fat without affecting muscle mass